The long-term effects of tibolone on aortic stiffness and endothelial function

Climacteric

Volumn 8, Issue 3, 2005, Pages 221-229

  Bruce, D ^a,c   Rymer, J ^a   Robinson, J ^a   Millasseau, S ^b   Chowienczyk, P ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

^c GUY S HOSPITAL   (United Kingdom)

Author keywords

Aortic stiffness; Cardiovascular disease; Endothelial function; Long term; Tibolone

Indexed keywords

TIBOLONE;

AORTA ATHEROSCLEROSIS; ARTERY BLOOD FLOW; ARTICLE; BLOOD VESSEL REACTIVITY; BRACHIAL ARTERY; CONTROLLED STUDY; CORONARY ARTERY DILATATION; DRUG EFFICACY; FEMALE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; OUTCOMES RESEARCH; PILOT STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; PULSE WAVE; TEACHING HOSPITAL; UNITED KINGDOM; VAGINA BLEEDING; VASCULAR ENDOTHELIUM;

AORTA; BLOOD FLOW VELOCITY; BRACHIAL ARTERY; CAROTID ARTERIES; CHOLESTEROL, HDL; CONTROLLED CLINICAL TRIALS; CROSS-SECTIONAL STUDIES; ENDOTHELIUM, VASCULAR; ESTROGEN RECEPTOR MODULATORS; FEMALE; FEMORAL ARTERY; HEMORHEOLOGY; HUMANS; LONDON; NORPREGNENES; PILOT PROJECTS; POSTMENOPAUSE; PROSPECTIVE STUDIES; PULSATILE FLOW; SMOKING; VASODILATION;

EID: 24044471629     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.1080/13697130500103441     Document Type: Article

References (63)

1. Newton JN. The epidemiology of coronary heart disease and HRT. What are the contentious issues? J Br Men Soc 1998;4:135-42
2. Stampfer MJ, Colditz GA. Estrogen replacement and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med 1991;20:47-63
3. Grodstein F, Stampfer MJ, Manson JE, et al. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med 1996;335:453-61
4. Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in post-menopausal women. JAMA 1998;280:605-13
5. Grodstein F, Manson JE, Stampfer MJ. Post-menopausal hormone use and secondary prevention of coronary events in the Nurses' Health Study. A prospective, observational study. Ann Intern Med 2001;135:1-8
6. Women's Health Initiative. National Institutes of Health, National Heart, Lung and Blood Institute. www.nhlbi.nih.gov/whi/hrt-en. htn.2000. Ref Type: Electronic Citation
7. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA 2002;288:321-33
8. Media Statement - Discontinuation of the WISDOM study. www.mrc.ac.uk. 2002. Ref Type: Internet Communication
9. The Writing Group for the PEPI trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA 1995;273:199-208
10. van Baal WM, Kooistra T, Stehouwer CD. Cardiovascular disease risk and hormone replacement therapy (HRT): a review based on randomised, controlled studies in postmenopausal women. Curr Med Chem 2000;7:499-517
11. McGrath BP, Liang YL, Teede H, Shiel LM, Cameron JD, Dart A. Age-related deterioration in arterial structure and function in postmenopausal women: impact of hormone replacement therapy. Arterioscl Thromb Biol 1998;18:1149-56
12. Kelly RP, Hayward CS, Avolio AP, O'Rourke MF. Non-invasive determination of age related changes in the human arterial pulse. Circulation 1989;80:1652-9
13. Cohn JN, Finkelstein S, McVeigh G, et al. Noninvasive pulse wave analysis for the early detection of vascular disease. Hypertension 1995;26:503-8
14. Asmar R, Benetos A, Topouchian J, et al. Assessment of arterial distensibility by automatic pulse wave velocity measurement. Hypertension 1995;26:485-90
15. Marcus RH, Korcarz C, McCray G, et al. Noninvasive method for determination of arterial compliance using doppler echocardiography and subclavian pulse tracings. Validation and clinical application of a physiological model of the circulation. Circulation 1994;89:2688-99
16. Millasseau SC, Guigui FG, Kelly RP, et al. Noninvasive assessment of the digital volume pulse: comparison with the peripheral pressure pulse. Hypertension 2000;36:952-6
17. Lehmann ED, Watts GF, Fatemi-Langroudi B, Gosling RG. Aortic compliance in young patients with heterozygous familial hypercholesterolaemia. Clin Sci 1992;83:717-21
18. Hickler RB. Aortic and large artery stiffness: current methodology and clinical correlations. Clin Cardiol 1990;13:317-22
19. Nichols WW, O'Rourke MF. McDonald's Blood Flow in Arteries. London: Edward Arnold, 1990
20. Rajkumar C, Kingwell BA, Cameron JD, et al. Hormone therapy increases arterial compliance in postmenopausal women. J Am Coll Cardiol 1997;30:350-6
21. Liang YL, Teede H, Shiel LM, et al. Effects of oestrogen and progesterone on age-related changes in arteries of postmenopausal women. Clin Exp Pharmacol 1997;24:457-9
22. Zeiher AM, Drexler H, Wollschlager H, Just H. Modulation of coronary vasomotor tone in humans: progressive endothelial dysfunction with different early stages of atherosclerosis. Circulation 1991;83:391-401
23. Panza JA, Quyyumi AA, Brush JEJ, Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990;323:22-7
24. Panza JA, Casino PR, Kilcoyne CM, Quyyumi AA. Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation 1993;87:1468-74
25. Creager MA, Gallagher SJ, Girerd XJ, Coleman SM, Dzau VJ, Cooke JP. L-Arginine improves endothelium-dependent vasodilation in hypercholesterolemic patients. J Clin Invest 1992;90: 1248-53
26. Casino PR, Kilcoyne CM, Quyyumi AA, Hoeg JM, Panza JA. Role of nitric oxide in the endothelium-dependent vasodilation of hypercholesterolemic patients. Circulation 1993;88: 2541-7
27. McVeigh GE, Brennan GM, Johnstone GD. Impaired endothelium-dependent and independent vasodilation with type 2 (non-insulin dependent) diabetes mellitus. Diabetologia 1992;35:771-6
28. Johnstone MT, Creager SJ, Scales KM, Cusco JA, Lee BK, Creager MA. Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation 1993;88:2510-16
29. Celermajer DS, Sorensen KE, Bull C, Robinson J, Deanfield JE. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to the coronary risk factors and their interaction. J Am Coll Cardiol 1994;24:1468-74
30. Kim-Schulze S, McGowan KA, Hubehak SC, et al. Expression of an estrogen receptor by human coronary artery and umbilical vein endothelial cells. Circulation 1996;94:1402-7
31. Karas RH, Patterson BL, Mendelsohn ME. Human vascular smooth muscle cells contain functional estrogen receptor. Circulation 1994; 89:1943-50
32. Losordo DW, Kearney M, Kim EA, Jekanowski J, Isner JM. Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women. Circulation 1994;89:1501-10
33. Imthurn B, Rosselli M, Jager AW, Keller PJ, Dubey RK. Differential effects of hormone-replacement therapy on endogenous nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17 beta-estradiol valerate and cyproterone acetate or medroxyprogesterone acetate. J Clin Endocrinol Metab 1997;82: 388-94
34. Joannides R, Haefeli WE, Linder L, et al. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation 1995;91:1314-19
35. Celermajer DS, Sorensen KE, Gooch VM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992;340:1111-15
36. Doshi SN, Lewis MJ, Goodfellow J. Improving endothelial vasomotor function may reduce cardiovascular risk, but the current evidence is circumstantial. Br Med J 2001;323:352-3
37. Lieberman EH, Gerhard MD, Uehata A, et al. Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women. Ann Intern Med 1994;121:936-41
38. Koh KK, Cardillo C, Bui MN, et al. Vascular effects of estrogen and cholesterol lowering therapies in hypercholesterolemic postmenopausal women. Circulation 1999;99:354-60
39. Herrington DM, Werbel BL, Riley WA, Pusser BE, Morgan TM. Individual and combined effects of estrogen/progestin therapy and lovastatin on lipids and flow-mediated vasodilation in postmenopausal women with coronary heart disease. J Am Coll Cardiol 1999;33:2030-7
40. Sorensen KE, Dorup I, Hermann AP, Mosekilde L. Combined hormone replacement therapy does not protect women against the age-related decline in endothelium-dependent vasomotor function. Circulation 1998;97:1234-8
41. Teede HJ, Liang YL, Kotsopoulos D, Zoungas S, Craven R, McGrath BP. A placebo-controlled trial of long-term oral combined continuous hormone replacement therapy in postmenopausal women: effects on arterial compliance and endothelial function. Clin Endocrinol 2001; 55:673-82
42. Hammar M, Christau S, Nathorst-Boos J, Rud T, Garre K. A double-blind, randomised trial comparing the effects of tibolone and continuous combined hormone replacement therapy in postmenopausal women with menopausal symptoms. Br J Obstet Gynaecol 1998;105:904-11
43. Morris EP, Wilson PO, Robinson J, Rymer J. Long term effects of tibolone on the genital tract in postmenopausal women. Br J Obstet Gynaecol 1999;106:954-9
44. Lehmann ED, Hopkins KD, Parker JR, et al. Aortic distensibility in post-menopausal women receiving tibolone. Br J Radiol 1994;67:701-5
45. de Kleijn MJ, Wilmink HW, Bots ML, et al. Hormone replacement therapy and endothelial function. Results of a randomized controlled trial in healthy postmenopausal women. Atherosclerosis 2001;159:357-65
46. Stadler RW, Karl WC, Lees RS. New methods for arterial diameter measurement from B-mode images. Ultrasound Med Biol 1996;22:25-34
47. Stadler RW, Taylor JA, Lees RS. Comparison of B-mode, M-mode and echo-tracking methods for measurement of the arterial distension wave-form. Ultrasound Med Biol 1997;23:879-87
48. Leeson P, Thorne S, Donald A, Mullen M, Clarkson P, Deanfield JE. Non-invasive measurement of endothelial function: effect on brachial artery dilatation of graded endothelial dependent and independent stimuli. Heart 1997;78:22-7
49. Quan H, Shih WJ. Assessing reproducibility by the within-subject coefficient of variation with random effects models. Biometrics 1996;52: 1195-203
50. Simon JA, Hsia J, Cauley JA, et al. Postmenopausal hormone therapy and risk of stroke. The Heart and Estrogen-progestin Replacement Study (HERS). Circulation 2001;103:638-42
51. Grady D, Herrington D, Bittner V, et al. Cardiovascular disease outcomes during 6.8 years of hormone therapy. Heart and Estrogen/ progestin Replacement Study follow-up (HERS II). JAMA 2002;288:49-57
52. Rymer JM. The effects of tibolone. Gynecol Endocrinol 1998;12:213-20
53. Hemminki E, Malin M, Topo P. Selection to postmenopausal therapy by women's characteristics. J Clin Epidemiol 1993;46:211-19
54. Posthuma WFM, Westendorp RGJ, Vandenbroucke JP. Cardioprotective effect of hormone replacement therapy in postmenopausal women: is the evidence biased? Br Med J 1994;308: 1268-9
55. Sturgeon SR, Schairer C, Brinton LA, Pearson T, Hoover RN. Evidence of a healthy estrogen user survivor effect. Epidemiology 1995;6:207-8
56. Haenggi W, Bersinger NA, Mueller MD, Birkhaeuser MH. Decrease of serum endothelin levels with postmenopausal hormone replacement therapy or tibolone. Gynecol Endocrinol 1999;13:202-5
57. Hardiman P, Nihoyannopoulos P, Kicovic P, Ginsburg J. Cardiovascular effects of Org OD14 - a new steroidal therapy for climacteric symptoms. Maturitas 1991;13:235-42
58. Ceballos C, Ribes C, Amado JA, de Mier I, de Rozas LS, Berrazueta JR. Venous endothelial function in postmenopausal women after six months of tibolone therapy. Maturitas 2001; 39:63-70
59. Lloyd GWL, Patel NR, McGing EA, Cooper AF, Kamalvand K, Jackson G. Acute effects of hormone replacement therapy with tibolone on myocardial ischaemia in women with angina. Int J Clin Pharmacol 1998;52:155-7
60. Liang YL, Teede H, Kotsopoulos D, et al. Non-invasive measurements of arterial structure and function; repeatability, interrelationships and trial sample size. Clin Sci 1998;95:669-79
61. Bush DE, Jones CE, Bass KM, Walters GK, Bruza JM, Ouyang P. Estrogen replacement reverses endothelial dysfunction in postmenopausal women. Am J Med 1998;104:552-8
62. Mares P, Dauzat M, Abramovici Y, et al. Effects of a sequential combination of estradiol valerate and cyproterone acetate on the functional properties of the arterial wall in menopausal women. Gynecol Obstet Fertil 2000;28:509-17
63. Wakatsuki A, Okatani Y, Ikenoue N, Fukaya T. Effect of medroxyprogesterone acetate on endothelium-dependent vasodilation in postmenopausal women receiving estrogen. Circulation 2001;104:1773-8